Impax Laboratories Inc
Michael Nestor currently serves as President of Impax Pharmaceuticals, a position held since March 2008. In addition, Michael Nestor has held the title of President at IMPAX Labs since 2008. Prior experience includes serving as President at Alpharma from 2001 to 2003 and as VP/GM at Wyeth Lederle from 1994 to 1996.
This person is not in any teams
Impax Laboratories Inc
Impax Laboratories, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. Its segments include Impax Generics and Impax Specialty Pharma. The Impax Generics segment is focused on the development, manufacture, sale and distribution of its generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their established drug names. The Impax Specialty Pharma segment is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease, post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.